Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/23/2010WO2010147144A1 Oral liquid preparation
12/23/2010WO2010147138A1 Gene encoding fatty acid elongase, and use thereof
12/23/2010WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor
12/23/2010WO2010146881A1 Substituted isoquinoline derivative
12/23/2010WO2010146872A1 Composition for external application comprising aripiprazole and organic acid as active ingredients
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010146351A1 Indolylmethyl-morpholine derivatives as kinase inhibitors
12/23/2010WO2010146309A1 Mother-of-pearl composition for using in the treatment of lesions in the nervous system, neurogenic substrate comprising said composition, and method for the production thereof
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146150A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
12/23/2010WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders
12/23/2010WO2010146025A1 Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
12/23/2010WO2010145989A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145668A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
12/23/2010WO2010145208A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof
12/23/2010WO2010145206A1 Preparation methods of optical isomers of stepholidine or its derivatives and intermediates thereof
12/23/2010WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof
12/23/2010WO2010119161A3 Antiepileptic, hypocholesterolemic and neuroprotective compound
12/23/2010WO2010100651A4 Compositions of polymeric myrcene
12/23/2010WO2010080757A3 Combinations with an alpha-4beta-2 nicotinic agonist
12/23/2010WO2010079045A3 Crystalline salt forms of flibanserine
12/23/2010US20100324291 Processes for 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof
12/23/2010US20100324274 Novel synthetic ganglioside derivatives and compositions thereof
12/23/2010US20100324144 Therapy for hyperexcitability disorders
12/23/2010US20100324141 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof
12/23/2010US20100324139 Process to pregabalin
12/23/2010US20100324131 Salvinorin Derivatives and Uses Thereof
12/23/2010US20100324127 Treating neurodegenerative diseases with progranulin
12/23/2010US20100324106 Compounds
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/23/2010US20100324099 Sustained release aminopyridine compositions
12/23/2010US20100324098 Sustained release aminopyridine compositions
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324085 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324080 Benzomorphan Compounds
12/23/2010US20100324078 Crystalline Forms of Naltrexone Methobromide
12/23/2010US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds
12/23/2010US20100324072 Pyrrolopyridine derivatives and their use as bace inhibitors
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324064 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
12/23/2010US20100324062 Compounds and compositions as protein kinase inhibitors
12/23/2010US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324055 Solid states forms of varenicline salts and processes for preparation thereof
12/23/2010US20100324053 Trisubstituted 1,2,4 triazoles
12/23/2010US20100324051 Novel compounds as opioid receptor modulators
12/23/2010US20100324050 Inhibitors of bruton's tyrosine kinase
12/23/2010US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor
12/23/2010US20100324044 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/23/2010US20100324032 Compounds and uses thereof in modulating amyloid beta
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324028 Novel compounds
12/23/2010US20100324027 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/23/2010US20100324024 Quinolizidinone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324023 Imidazobenzazepine cgrp receptor antagonists
12/23/2010US20100324022 Novel compounds
12/23/2010US20100324020 Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323995 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
12/23/2010US20100323993 Uses of pentamidine and related compounds
12/23/2010US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
12/23/2010US20100323982 Food composition for prodromal dementia patients
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323974 Inhibitors of PARP Activity and Uses Thereof
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
12/23/2010US20100323949 erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
12/23/2010US20100323366 Methods of Selecting a Dopaminergic Neuron Proliferative Progenitor Cells Using LRP4/CORIN Markers
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323027 Mesenchymal stem cell conditioned medium
12/23/2010US20100323017 Escitalopram and Solid Pharmaceutical Composition Comprising the Same
12/23/2010US20100323016 Modified release formulation and methods of use
12/23/2010US20100323015 Modified release formulation and methods of use
12/23/2010US20100322999 Fentanyl-containing patch for external use
12/23/2010US20100322985 Effervescent compositions
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders
12/23/2010US20100322938 Novel clusterin derived peptide
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322921 METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOF
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 1833